恒瑞医药、百济神州快跑,多药企多点开花!中国创新药矩阵持续扩容

制药网
Mar 09

近年来,在政策持续赋能、企业深耕研发等背景下,国内创新药不断崛起,并涌现出如恒瑞医药、百济神州等一批代表性的企业,它们凭借差异化布局、核心技术突破、全球化视野,不断破局,实现跨越。其中,恒瑞医药国内化学制药实力担当,比较有机会挑战国际医药头部的中国制药公司。2025年,恒瑞医药的创新布局进入收获期,其中,海外BD项目方面,恒瑞医药已累计实现13笔创新药海外授权合作,交易总额近140亿美元,除与...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10